Generation of denritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells

Human Immunology

Volumn 53, Issue 2, 1997, Pages 216-223

  Smit, Willem M ^a,b   Rijnbeek, Marion ^a,b   Van Bergen, Cornelis A M ^a,b   De Paus, Roelof A ^a,b   Vervenne, Henricus A W ^a,b   Van De Keur, Maarten ^a,b   Willemze, Roel ^a,b   Falkenburg, J H Frederik ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; BCR ABL PROTEIN; MESSENGER RNA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CHRONIC MYELOID LEUKEMIA; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; RELAPSE; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CELL CYCLE; CYTOLOGY; GENETICS; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANTIGENS, CD34; BONE MARROW CELLS; CELL CYCLE; CELLS, CULTURED; DENDRITIC CELLS; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE ACTIVATION; RNA, MESSENGER; TRANSLOCATION, GENETIC;

EID: 0030611672     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(96)00285-6     Document Type: Article

References (27)

1. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H: Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86:2041, 1995.
2. Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs BH, Gillio AP, Kernan NA, Small TN, Young JW, O'Reilly RJ: Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 86:1261, 1995.
3. Faber LM, van Luxemburg-Heys SAP, Willemze R, Falkenburg JHF: Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med 176:1283, 1992.
4. Falkenburg JHF, Faber LM, van den Elshout M, van Luxemburg-Heys SAP, Hooftman-den Otter A, Smit WM, Voogt PJ, Willemze R: Generation of donor-derived antileukemic cytotoxic T lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantation. J Immunother 14:305, 1993.
5. Falkenburg JHF, Willemze R: Donor cell mediated antileukemic reactivity after allogeneic bone marrow transplantation. Curr Opin Hematol 228, 1993.
6. Bocchia M, Wentworth PA, Southwood S, Sidney J, McGraw K, Scheinberg DA, Sette A: Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood 85:2680, 1995.
7. bcr-abl protein. Proc Natl Acad Sci 89:1468, 1992.
8. bcr-abl protein by human T cells. Leukemia 9:1344, 1995.
9. Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA: Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 87: 3587, 1996.
10. Van Lochem E, de Gast B, Goulmy E: In vitro separation of host specific graft-versus-host and graft-versus leukemia cytotoxic T cell activities. Bone Marrow Transplant 10:181, 1992.
11. 1- cells from the same patient. Blood 83:3390, 1994.
12. Van Lochem EG, Bakker A, Snijder S, Aarts M, de Gast GC, Goulmy E: Epstein-Barr virus infection abrogates the stimulatory capacity of B cells to a major histocompatibility complex class-II-restricted proliferative T-cell clone. Hum Immunol 42:137, 1995.
13. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM: Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84: 3261, 1994.
14. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258, 1992.
15. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE: TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leuk Biol 52:274, 1992.
16. + progenitors in human bone marrow. J Immunol 149:2681, 1992.
17. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J Immunol 154:5851, 1995.
18. Freudental PS, Steinman RM: The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 87:7698, 1990.
19. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179:1109, 1994.
20. van de Rijke FM, Vrolijk H, Sloos W, Tanke HJ, Raap AK: Sample preparation and in situ hybridization techniques for automated molecular cytogenetic analysis of white blood cells. Cytometry (in press).
21. Maurer J, Thiel E: PCR-based rapid detection of the Philadelphia-chromosome in chronic myelogenous and acute lymphoblastic leukemia, in Rolfs A, Schumacher H Chr, Marx P (eds): PCR Topics, usage of polymerase chain reaction in genetic and infectious diseases. Berlin, Springer-Verlag, 1991, p 234.
22. Santiago-Schwarz F, Divaris N, Kay C, Carsons SE: Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development. Blood 82:3019, 1993.
23. Romani N, Gruner S, Brang D, Kämpgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83, 1994.
24. Jansen JH, Wientjes GJHM, Fibbe WE, Willemze R, Kluin-Nelemans JC: Inhibition of human macrophage colony formation by interleukin 4. J Exp Med 170:577, 1989.
25. + bone marrow. Blood 86:420a, 1995.
26. + blood progenitors for anticancer therapy. Exp Hematol 23:1463, 1995.
27. + helper T cells. J Exp Med 171:1315, 1990.